We are live on !
Find out more
Rockingstone Advisors Portfolio holdings
AUM
$249M
Turnover
5.98%
1-Year Est. Return
27.79%
This Fund
S&P 500
This Quarter Est. Return
+3.71%
1 Year Est. Return
+27.79%
3 Year Est. Return
+114.14%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$249M
AUM Growth
-$479K
(-0.19%)
Cap. Flow
-$4.67M
Cap. Flow % of AUM
Cap. Flow %
-1.88%
Top 10 Holdings %
Top 10 Hldgs %
30.16%
Holding
117
New
2
Increased
35
Reduced
37
Closed
5
Avg Time Held
2.9
years
Top 10 Avg Time Held
1.7
years
Top 20 Avg Time Held
2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$2.66M |
| 2 |
SPDR Gold Trust
GLD
|
+$2.52M |
| 3 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$873K |
| 4 |
Navan Inc
NAVN
|
+$422K |
| 5 |
iShares Floating Rate Bond ETF
FLOT
|
+$306K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceutical Industries Limited
TEVA
|
+$3.22M |
| 2 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$3.12M |
| 3 |
Omnicom Group
OMC
|
+$2.7M |
| 4 |
U.S. Core Equity 2 Portfolio ETF Class Shares
DFAC
|
+$642K |
| 5 |
Tower Semiconductor
TSEM
|
+$429K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 47.64% |
| 2 | Technology | 18.22% |
| 3 | Communication Services | 6.86% |
| 4 | Financials | 6.01% |
| 5 | Healthcare | 5.57% |
Similar funds
AFT
Rockingstone Advisors's Q3 2026 Portfolio in Review
As of Q3 2026, Rockingstone Advisors held 117 positions worth $249M, down 0.19% from $249M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Rockingstone Advisors's Q3 2026 filing shows 2 new, 35 increased, 37 reduced and 5 closed positions. Its largest new stake was Chevron: 13,507 shares worth $2.76M. The largest sale was Teva Pharmaceutical Industries Limited, an estimated $3.22M.
By sector, the portfolio is most concentrated in Miscellaneous at 48% of assets, up from 48% a quarter earlier, followed by Technology and Communication Services.
- Rockingstone Advisors's largest Q3 2026 buy was Chevron: 13,507 shares worth $2.76M.
- Rockingstone Advisors added most to SPDR Gold Trust in Q3 2026, an estimated $2.52M increase.
- Rockingstone Advisors's biggest Q3 2026 reduction was Vanguard Short-Term Treasury ETF, cutting an estimated $3.12M.
- Rockingstone Advisors fully exited Teva Pharmaceutical Industries Limited in Q3 2026, selling an estimated $3.22M.
- Rockingstone Advisors's ten largest holdings make up 30% of its $249M portfolio in Q3 2026.
- Rockingstone Advisors opened 2 new positions and closed 5 in Q3 2026.
- Rockingstone Advisors's portfolio value fell 0.19% quarter-over-quarter to $249M.
Based on Rockingstone Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.